Detailed comparison of the safety of tivozanib versus sorafenib in patients with advanced/metastatic renal cell carcinoma (mRCC) from a phase 3 trial Meeting Abstract


Authors: Eisen, T. Q. G.; Sternberg, C. N.; Tomczak, P.; Harza, M.; Jinga, V.; Esteves, B.; Motzer, R. J.
Abstract Title: Detailed comparison of the safety of tivozanib versus sorafenib in patients with advanced/metastatic renal cell carcinoma (mRCC) from a phase 3 trial
Meeting Title: 37th Congress of the European Society for Medical Oncology (ESMO)
Journal Title: Annals of Oncology
Volume: 23
Issue: Suppl. 9
Meeting Dates: 2012 Sep 28-Oct 2
Meeting Location: Vienna, Austria
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2012-09-01
Start Page: ix262
End Page: ix263
Language: English
ACCESSION: WOS:000309409001277
PROVIDER: wos
PUBMED: 23012731
DOI: /10.1016/S0923-7534(20)33361-5
Notes: Meeting Abstract: 795PD -- "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1248 Motzer